Publications by authors named "Voronin E"

A series of new types of composites (biopolymer-silica materials) are proposed as selective and effective adsorbents. A new procedure for the synthesis of chitosan-nanosilica composites (ChNS) and chitosan-silica gel composites (ChSG) using geometrical modification of silica and mechanosorption of chitosan is applied. The highest adsorption efficiency was achieved at pH = 2, hence the desirability of modifications aimed at stabilizing chitosan in such conditions.

View Article and Find Full Text PDF

The influence of the geometric modification (GM) of fumed nanoscale silica A300 (NS) on the adsorption capacity of human serum albumin (HSA) as well as the physicochemical and textural properties of the protein/nanosilica system was analyzed. An effective medical enterosorbent based on fumed nanosilica was designed and produced in the Chuiko Institute of Surface Chemistry, National Academy of Sciences of Ukraine. To design an effective nanomaterial for biomedical applications as a wound-healing material, the adsorption, physicochemical and surface properties of the initial nanosilica (NS), nanosilica after geometric modification (GM-nanosilica), and HSA/nanosilica biocomposites were characterized.

View Article and Find Full Text PDF
Article Synopsis
  • Etravirine (ETR) is used for second or third-line antiretroviral treatment in children with HIV, and a study assessed its outcomes in children across Europe and Thailand.
  • Data was collected from 177 children, showing that 69% achieved viral suppression after 12 months and experienced an increase in CD4 cell counts; however, 46% discontinued ETR due to reasons such as treatment simplification and failure.
  • Some adverse events were reported, including rare but serious reactions like Stevens-Johnson Syndrome, but overall, ETR proved effective for many treatment-experienced children.
View Article and Find Full Text PDF
Article Synopsis
  • Bictegravir combined with emtricitabine/tenofovir alafenamide (B/F/TAF) is an effective and well-tolerated HIV treatment, showing no resistance in treatment-naive and suppressed patients for 48 weeks.* -
  • In a phase 3 trial, 472 women with suppressed HIV were randomly assigned to either switch to B/F/TAF or continue their current regimen, with results demonstrating that switching was as effective as staying on the original treatment.* -
  • The study highlights B/F/TAF as a safe option for women living with HIV, providing essential insights into the efficacy and tolerability of antiretroviral therapy specifically for this group.*
View Article and Find Full Text PDF

Background: Women are under-represented in HIV antiretroviral therapy (ART) studies. Guidelines for selection of ART as initial therapy in patients with HIV-1 infection do not contain sex-specific treatment. We aimed to assess the safety and efficacy of the single tablet integrase inhibitor regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate compared with a boosted protease inhibitor regimen of ritonavir-boosted atazanavir with emtricitabine and tenofovir disoproxil fumarate.

View Article and Find Full Text PDF

Treatment-emergent mutations and drug resistance were analyzed in virus from HIV-infected children meeting virologic failure (VF) criteria over 48 weeks following treatment with unboosted fosamprenavir or fosamprenavir/ritonavir-containing regimens in studies APV20002 and APV29005. Both antiretroviral therapy (ART)-naïve and ART-experienced patients were enrolled. Patients met VF criteria by either failing to suppress HIV-RNA to <400 copies/mL through week 24 or after confirmed viral rebound (≥400 copies/mL) anytime through week 48.

View Article and Find Full Text PDF

The use of antiretroviral drugs (ARVDs) in a mother and a child can reduce the risk of vertical transmission of human immunodeficiency virus (HIV) to less than 1%; therefore, highly active antiretroviral therapy is used in all pregnant women regardless of indications for HIV-infection treatment. The major requirements for choosing an ARVD to prevent mother-to-child HIV transmission are its high safety for a pregnant woman, a fetus, and a baby and its high therapeutic efficacy. Clinical trials of darunavir (DRV) in adults and children have shown a high virologic response, good tolerance, and safety.

View Article and Find Full Text PDF

Objective: To evaluate the efficacy and safety/tolerability of dolutegravir (DTG, S/GSK1349572), a potent inhibitor of HIV integrase, through the full 96 weeks of the SPRING-1 study.

Design: ING112276 (SPRING-1) was a 96-week, randomized, partially blinded, phase IIb dose-ranging study.

Methods: Treatment-naive adults with HIV received DTG 10, 25, or 50 mg once daily or efavirenz (EFV) 600 mg once daily (control arm) combined with investigator-selected dual nucleos(t)ide reverse transcriptase inhibitor backbone regimen (tenofovir/emtricitabine or abacavir/lamivudine).

View Article and Find Full Text PDF

Background: The HIV epidemic in Russia has increasingly involved reproductive-aged women, which may increase perinatal HIV transmission.

Methods: Standard HIV case-reporting and enhanced perinatal HIV surveillance systems were used for prospective assessment of HIV-infected women giving birth in St. Petersburg, Russia, during 2004-2008.

View Article and Find Full Text PDF

The structural, textural, and adsorption characteristics of mechanochemically activated (MCA) fumed silica A-300 as dry or water, ethanol, or water/ethanol-wetted powders (0.5 g of a solvent per gram of silica) in a ball mill for 1-6 h were studied in comparison with those of the initial powder. The MCA treatment enhances bulk density (ρ(b)) of the powder (from 0.

View Article and Find Full Text PDF

Background: The present primary analysis of AntiRetroviral Therapy with TMC114 ExaMined In naive Subjects (ARTEMIS) compares the efficacy and safety of once-daily darunavir/ritonavir (DRV/r) with that of lopinavir/ritonavir (LPV/r) in treatment-naive patients.

Methods: Patients with HIV-1 RNA at least 5000 copies/ml were stratified by HIV-1 RNA and CD4 cell count in a phase III, open-label trial, and randomized to receive DRV/r 800/100 mg qd or LPV/r 800/200 mg total daily dose (bid or qd) plus fixed-dose tenofovir and emtricitabine for 192 weeks. The primary objective was to demonstrate non-inferiority of DRV/r as compared with LPV/r in HIV-1 RNA less than 50 copies/ml per-protocol time-to-loss of virologic response at 48 weeks.

View Article and Find Full Text PDF

Objective: The purpose of this study was to evaluate the effectiveness of a human immunodeficiency virus (HIV) rapid testing (RT) program.

Study Design: From April 13, 2004, to April 13, 2005, pregnant women at 2 high-risk maternity hospitals with no or incomplete HIV testing results (negative tests at <34 weeks, none thereafter) were offered point-of-care RT, with antiretroviral prophylaxis for RT-positive women and their infants.

Results: Overall, 89.

View Article and Find Full Text PDF

In St Petersburg, Russia, a rapid HIV-testing programme was implemented in April 2004 for high-risk women giving birth. Among 670 women without prenatal care who received rapid HIV testing, 6.4% (43) had positive results.

View Article and Find Full Text PDF

Successive interaction of different pairs of water-soluble polymers (poly(ethylene glycol) (PEG), poly(vinyl pyrrolidone) (PVP), poly(vinyl alcohol) (PVA)), proteins (bovine serum albumin (BSA), ovalbumin, gelatin, and ossein), and smaller organics such as lecithin (1-stearoyl-2-oleoyl phosphatidylcholine, SOPC) and Aethonium (1,2-ethylene-bis(N-dimethyl carbodecyl oxymethyl) ammonium dichloride) with nanosilicas A-300 (S(BET)=232 and 297 m(2) g(-1)) and A-50 (S(BET)=52 m(2)g(-1)) was studied using dynamic light scattering, adsorption, and infrared (FTIR) spectroscopy methods. Time-dependent rearrangement of particle size distributions (PSDs) depicts appearance of both smaller and larger aggregates for silica/PEG(I-first adsorbate)/BSA(II-second adsorbate) and silica/PVP(I)/BSA(II) (i.e.

View Article and Find Full Text PDF

Several series of fumed silicas and mixed fumed oxides produced and treated under different conditions were studied in gaseous and liquid media using nitrogen and water adsorption-desorption, mass spectrometry, FTIR, NMR, thermally stimulated depolarization current (TSDC), photon correlation spectroscopy (PCS), zeta potential, potentiometric titration, and Auger electron spectroscopy methods. Aggregation of primary particles and adsorption capacity (Vp) decrease and hysteresis loops of nitrogen adsorption-desorption isotherms becomes shorter with decreasing specific surface area (S(BET)). However, the shape of nitrogen adsorption-desorption isotherms can be assigned to the same type independent of S(BET) value.

View Article and Find Full Text PDF

Interaction of poly(ethylene oxide) (PEO, 600 kDa) with fumed silica A-300 (SBET = 316 m2/g) was investigated under different conditions using adsorption, infrared (IR), thermal analysis (TG-DTA), AFM, and quantum chemical methods. The studied dried silica/PEO samples were also carbonized in a flow reactor at 773 K. The structural characteristics of fumed silica, PEO/silica, and pyrocarbon/fumed silica were investigated using nitrogen adsorption-desorption at 77.

View Article and Find Full Text PDF

The effectiveness of rapid HIV-1 testing and nevirapine prophylaxis for HIV-infected mothers without prenatal care has been shown. We found that from 1998 to 2002, HIV-1 seroprevalence in women giving birth in St Petersburg, Russia increased 100-fold: from 0.013% to 1.

View Article and Find Full Text PDF

Background: 274 children were HIV-infected during 1988-89 in hospitals in the South of Russia during treatment of heavy pathology requiring an intensive therapy and catheterization of large venous vessels. Today only 140 children, receiving HAART now, remain alive.

Patients And Methods: In 1988 - 89 mothers having nosocomially HIV-infected children were tested on a 'WHOQOL-100' technique (Russian version).

View Article and Find Full Text PDF

Fumed oxide alumina/silica/titania was studied in comparison with fumed alumina, silica, titania, alumina/silica, and titania/silica by means of XRD, (1)H NMR, IR, optical, dielectric relaxation, and photon correlation spectroscopies, electrophoresis, and quantum chemical methods. The explored Al(2)O(3)/SiO(2)/TiO(2) consists of amorphous alumina ( approximately 22 wt%), amorphous silica ( approximately 28 wt%), and crystalline titania ( approximately 50 wt%, with a blend of anatase (88%) and rutile (12%)) and has a wide assortment of Brønsted and Lewis acid sites, which provide a greater acidity than that of individual fumed alumina, silica, or titania and an acidity close to that of fumed alumina/silica or titania/silica. The changes in the Gibbs free energy (DeltaG) of interfacial water in an aqueous suspension of Al(2)O(3)/SiO(2)/TiO(2) are close to the DeltaG values of the dispersions of pure rutile but markedly lower than those of alumina, anatase, or rutile covered by alumina and silica.

View Article and Find Full Text PDF

The structure of porous silica gel/titania synthesized using chemical vapor deposition (CVD) of titania via repeated reactions of TiCl(4) with the surface and subsequent hydrolysis of residual Ti-Cl bonds at different temperatures was investigated by means of low-temperature nitrogen adsorption-desorption, X-ray diffraction (XRD), IR spectroscopy, and theoretical methods. A globular model of porous solids with corpuscular structure was applied to estimate the porosity parameters of titania/silica gel adsorbents. The utilization of this model is useful, for example, to predict conditions for synthesis of titania/silica with a specified structure.

View Article and Find Full Text PDF

The pronounced forms of depression and the levels of neuro-psychical adaptation and subjective control (attitude to the disease) were studied in 27 patients with HIV infection. 14 patients were at stage A, 8 patients were at stage B and 5 patients were at stage C of the CDC classification (1994). Starting from the early stages of the disease, neuro-psychical adaptation disturbances were noted: at stage A 10 patients belonged to group 5 of health, at stage B 8 patients and at stage C 2 patients.

View Article and Find Full Text PDF

The data on the study of the clinical course of HIV infection in 127 children, 124 from these infected in nosocomial foci. The overwhelming majority of the children were infected at the period of their stay in hospitals of Elista, Volgograd, Rostov-on-Don, Shakhty (Rostov Province) and Stavropol'. At the end of 9-9.

View Article and Find Full Text PDF

Morbidity in HIV infection and tuberculosis in persons having these two infections in association was analyzed. According to the data for the end of the first quarter of 1997 the presence of association of HIV infection with tuberculosis was found in 91 patients. In 70.

View Article and Find Full Text PDF